key: cord-1041641-m4vdn17v
authors: Anderson, Andrew; O’Connell, Samantha S.; Thomas, Christina; Chimmanamada, Rishab
title: Telehealth Interventions to Improve Diabetes Management Among Black and Hispanic Patients: a Systematic Review and Meta-Analysis
date: 2022-01-09
journal: J Racial Ethn Health Disparities
DOI: 10.1007/s40615-021-01174-6
sha: c1f5e29b09a7d9177296c623c6db2ac4c315a6dc
doc_id: 1041641
cord_uid: m4vdn17v

BACKGROUND: Previous systematic reviews have found that telehealth is an effective strategy for implementing interventions to improve glycemic control and other clinical outcomes for diabetes patients. However, these reviews have not meaningfully focused on Black and Hispanic patients—partly because of the lack of adequate representation of people from racial and ethnic minority groups in clinical trials. It is unclear whether telehealth interventions are effective at improving glycemic control among Black and Hispanic patients given the disproportionate number of barriers they face accessing health care. OBJECTIVES: A systematic review and meta-analysis of randomized control trials that used telehealth interventions for improving glycemic control among Black and Hispanic diabetes patients. METHODS: We reviewed PubMed, Embase, Web of Science, CINAHL, PsycINFO, and clinicalTrials.gov from inception to March 2021. We used a narrative summary approach to describe key study characteristics and graded the quality of studies using two reviewers. The pooled net change in HbA1c values was estimated across studies using a random-effects model. RESULTS: We identified 10 studies that met our inclusion and exclusion criteria. Nine studies were included in the meta-analysis. Only one study was rated as having low bias. Telehealth interventions were primarily delivered by telephone calls, text messages, web-based portals, and virtual visits. Most interventions involved delivering diabetes self-management education. Telehealth intervention pooled across studies with a mix of Black and Hispanic participants (> 50% sample) was associated with a − 0.465 ([CI: − 0.648 to − 0.282], p = 0.000) reduction in HbA1c. CONCLUSIONS: Our findings suggest telehealth interventions are effective at improving glycemic control among Black and Hispanic diabetes patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40615-021-01174-6.

The use of telecommunication, digital, and virtual technologies that expand access and improve continuity of care has the potential to improve the treatment and self-management of diabetes, particularly for Black and Hispanic patients. Black and Hispanic diabetes patients have worse outcomes and are more likely to be at risk for amputations, chronic kidney disease, and death compared to White patients [1] . These negative outcomes can be mediated by sustained glycemic control (i.e., HbA1c 7.0-8.5%) and timely access to primary care [2] . However, Black and Hispanic patients face greater barriers to accessing traditional, in-person health care. For instance, patients from racial and ethnic minority groups disproportionately experience transportation barriers resulting in missed appointments, delayed care, and lower medication use [3] [4] [5] . They are also less likely to have primary care near their communities compared to White patients (Arnett et al., 2016; Shi et al., 2014). These barriers are attributed to structural racism which is a basic cause of racial inequities in health care [6] [7] [8] . Telehealth has demonstrated effectiveness in reducing these barriers by decreasing the need to travel, the need to take off time from work for a doctor's appointment, the length of time to see a provider, as well as providing easier access to interpreters for people with limited English proficiency [9] .

Expanding access to telehealth has been recommended as a key strategy for reducing racial disparities in diabetes outcomes [10] . Telehealth can be used for improving education, prompting medication adherence, monitoring of vitals, and the application of direct treatments [11] . Yet, patients from racial and ethnic minority groups face barriers in accessing telehealth [12, 13] . Black and Hispanic patients are consistently less likely to have access to the Internet which is necessary for various modes of telehealth [14] . Also, patients with limited English proficiency are less likely to use telehealth compared to proficient English speakers [13] . A recent analysis of 7742 family medicine encounters preceding the Covid-19 pandemic found the likelihood of a telehealth visit was consistently lower for Black and Hispanic patients [15] . A study in a large health system in New York City found White patients were more likely to use telehealth, and Black and Hispanic patients were more likely to have office-based and emergency room visits during the pandemic [16] . Another study during the pandemic, at a large, urban tertiary care center in the Midwest, found Black patients were less likely to complete a scheduled telehealth visit [17] .

Various telehealth interventions have demonstrated effectiveness in improving glycemic control among people living with diabetes. Telehealth interventions that are used for routine evaluation and management of chronic diseases include web-based lifestyle interventions, telemonitoring, mobile messaging, telephone interventions, and many others [18] . Telehealth can facilitate remote treatment, continuous monitoring, and support for self-care, which can improve diabetes management. One meta-analysis of four systematic reviews found telehealth interventions produce a significant improvement in diabetes control, with the greatest effect for telephone-delivered interventions and internet-based blood glucose monitoring programs [19] . Another review of over 100 randomized control trials found telehealth is effective for glycemic control and other clinical outcomes and promotes better control over time compared to usual care [20] . However, these reviews have not meaningfully focused on patients from Black and Hispanic communities or empirically synthesized the findings across studies-partly because of the lack of representation of these patients in clinical trials. One systematic review of telehealth clinical trials for type 2 diabetes found less than 25% of trials recruited a sizeable proportion (> 30%) of patients from racial and ethnic minority groups [21] .

It is unclear whether telehealth interventions are effective at improving glycemic control among Black and Hispanic patients given the disproportionate number of barriers they face accessing health care, providing self-care, and accessing resources to engage in telehealth. The purpose of this systematic review and meta-analysis was to examine the existing literature for studies that have centered or substantively included Black and Hispanic diabetes patients in clinical trials to assess the effectiveness of telehealth interventions in improving glycemic control.

Interventions for improving diabetes outcomes have been categorized by their target including patients, providers, and health systems or combination multi-target interventions [22] . Conceptually, telehealth strengthens the connections between clinicians and other clinicians, between patients and their clinicians, and patients to other patients (e.g., peer support groups) [23] . Therefore, interventions can operate at multiple levels of the health care system to improve diabetes outcomes. Patients have a role in self-care (e.g., self-monitoring, variation of nutrition daily needs, insulin adjustments, and exercise) which is essential for sustained glycemic control [24] . Providers have a role in diagnosis, treatment, education, and coordination of care. Health care organizations and systems influence the overall structures of care (e.g., ensuring access to interpreters) and processes of care (e.g., proper routine screening to identify people at risk for diabetes or loss of control) that influence patient outcomes. Therefore, we categorized telehealth interventions based on the intended target for improving glycemic control [25] .

We reviewed PubMed, Embase, Web of Science, CINAHL, PsycINFO, and clinicalTrials.gov from inception to March 2021. Information sources were searched using the following Medical Subject Headings (MeSH) and keywords appropriate to each database: "Diabetes Mellitus," "type 2 diabetes," "Ethnic Groups," "African American," "Black," "Hispanic," "Latino," "Latina," "Latinx," "health inequality," and "health disparities." Databases were not limited by date, language, or publication status. In addition to database searching, reference lists of relevant review articles were manually searched to identify trials on the topics of telehealth and HbA1c improvement in racial and ethnic minority groups. To review the full search strategy, see the Supplemental Appendix. This systematic review was conducted following PRISMA guidelines.

We reviewed randomized controlled trials evaluating the effectiveness of telehealth interventions aimed at improving HbA1c values (i.e., glycemic control) among Black and Hispanic patients with type 2 diabetes connected to primary care. We defined telehealth as the delivery of health care, health education, and health information services by remote technologies [26] . We used the following inclusion criteria: telehealth interventions connected to primary care settings aimed at improving glycemic control (e.g., promotion of physical activity, nutritional/dietary education, glycemic self-monitoring, and remote outpatient visits); the sample included a majority of minority patients, Black and/or Hispanic; and reported HbA1c values as a primary or secondary outcome of the intervention. We excluded international studies because of the unique racial context in the USA. Studies were also excluded for the following reasons: telehealth was not the intervention, the sample included over 50% non-Hispanic white patients, and HbA1c values were not reported at baseline and post-intervention, publication type other than peer-reviewed primary research such as literature reviews, conference abstracts, or dissertations. To be included in the meta-analysis, studies were required to report the net change in HbA1c values and the standard error of the net change in HbA1c values, or information to calculate these values. Studies were excluded from meta-analysis if insufficient information was available.

Each study was screened independently and in duplicate by two reviewers using Covidence software. Titles and abstracts were screened using prespecified eligibility criteria. Those that appeared to meet eligibility criteria moved to full-text review. Full-text articles were further assessed for eligibility by two reviewers, independently and in duplicate. Articles that did not meet the prespecified eligibility criteria were excluded from the review. All discrepancies were resolved by a third reviewer.

Two reviewers independently abstracted data from each report using Qualtrics survey software. Data items were abstracted using a standardized abstraction form, modified from the Cochrane Collaboration [27] . Once data items were abstracted, all information was synthesized in Excel. Any discrepancies were resolved by a third reviewer. The following information was abstracted from each study: citation information (e.g., study author and year of publication), study methods (e.g., study design and duration of participation), participant characteristics (e.g., population description, setting from which participants were drawn, mean age, number of female and male participants, number of participants in each racial/ethnic minority group, education level, income, and baseline HbA1c values), intervention characteristics (e.g., number randomized to the intervention group, description of the intervention, duration of the treatment period, frequency of intervention delivery, mode of telehealth, and setting), comparison group characteristics (e.g., type of comparison group, number randomized to the group, description, duration of the control period, and providers), and HbA1c values at baseline and post-intervention.

The risk of bias within each study was assessed using the Cochrane Collaboration's tool for assessing risk of bias in randomized controlled trials [28] . Each study was assessed for selection bias, performance bias, reporting bias, and attrition bias by two independent reviewers. For each domain of bias, levels of bias were rated as high, low, or unclear. The approach recommended by the Cochrane Collaboration was used to generate the overall risk of bias for each study. If a study was judged to have low risk of bias for all domains, the overall risk of bias was categorized as low. If a study was judged to have low or unclear risk of bias for all domains, the overall risk of bias was categorized as unclear. Finally, if a study was judged to have a high risk of bias for at least one domain, the overall risk of bias was categorized as high.

For each study, we identified or calculated the net change in HbA1c. All studies included in the meta-analysis were parallel trials. Therefore, we calculated the net change of the telehealth intervention on HbA1c values by subtracting mean change (from baseline to post-intervention) in the telehealth group from the mean change in the control group. We obtained post-intervention HbA1c values from the final follow-up period of the study.

We used a narrative summary approach to describe key study characteristics (e.g., intensity and duration of telehealth intervention). We mapped studies based on the type of intervention to the conceptual framework developed by Chin et al. [22] . For studies included in meta-analysis, we extracted the baseline and post-intervention HbA1c values and measures of variance from each study. The net change was weighted for each trial by the inverse of its variance. If a trial's variance was not reported, it was calculated based on standard deviations, confidence intervals, or p values. Q and I 2 statistics were used to assess heterogeneity of effect sizes. The pooled net change and confidence interval were calculated using the Dersimonian and Laird random-effects model [29] . A forest plot was produced to visually assess the net change and corresponding 95% confidence intervals across studies. A funnel plot, using the trim and fill method, and the Egger test were used to assess publication bias. Unless otherwise stated, p < 0.05 was considered statistically significant, and all tests were two-sided. All syntheses were computed using Stata statistical software version 17.0 (StataCorp, College Station, Texas).

We conducted a subgroup analysis according to the race/ethnicity of study participants in each trial, whether the study had a focus or substantial representation (> 50% sample) of Black patients (Black or Black and Hispanic) or only Hispanic patients. To test whether our pre-selected criteria for representation of Black and Hispanic patients impacted our primary outcome, the net change in HbA1c, we conducted a sensitivity analysis excluding studies with any non-Hispanic White participants and found similar results. In addition, we conducted subgroup analyses according to study quality and intervention level. Study quality was divided into three groups: comparing low, unclear, or high risk of bias studies. Intervention level compared patient-level interventions to multifaceted interventions addressing community and patient-level factors. To assess the robustness of our findings, we examined whether racial or intervention level factors influenced our overall pooled effect estimate.

We identified 255 studies of possible relevance. We found 10 randomized control trials that met our predefined inclusion and exclusion criteria. Figure 1 shows the results of the search strategy. Most of the final studies deemed potentially relevant did not meet our definition of telehealth, did not include a representative sample of Black and/or Hispanic patients, or did not test their interventions in the context of a randomized controlled trial. Many studies met multiple criteria for exclusion but were only tagged with one exclusion criterion.

All interventions in our final sample of studies reported significant improvements in glycemic control among Black and Hispanic patients during the intervention period. The average duration of interventions, was 9 months, and the studies varied in the intensity of contact with participants from daily, weekly, to monthly-depending on the intervention modality. Telehealth interventions were primarily delivered by telephone calls [30] [31] [32] [33] , text messages [31, 34] , web-based portals [33, 35] , and virtual visits [36] . Patient-level only interventions primarily involved delivering diabetes self-management education (DSME) [30, 31, [34] [35] [36] . One patient-level intervention involved the use of remote monitoring devices assessing blood pressure control and blood glucose levels, pared with counseling and lifestyle recommendations specific to the patient [37] . Another intervention coupled DSME with a digital decision aid to help patients manage their goals [32] . Interventions often employed multiple implementation strategies (e.g., phone calls, text messages, and virtual counseling) instead of only one strategy. Only two studies used multi-target interventions as defined by our conceptual framework [33, 38] . Both multi-target interventions focused on improving the capacity and capability of community health workers through training Random sequence generation (RG)-described the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups Allocation concealment (AC)-described the method used to conceal the allocation sequence in sufficient detail to determine whether intervention allocations could have been foreseen before or during enrollment Reporting bias (RB)-stated how the possibility of selective outcome reporting was examined by the authors and what was found Performance bias (PB)-described all measures used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. Provided any information relating to whether the intended blinding was effective Attrition bias (AB)-incomplete outcome data-described the completeness of outcome data for each main outcome, including attrition and exclusions from the analysis. Stated whether attrition and exclusions were reported, the numbers in each intervention group (compared with total randomized participants), reasons for attrition/exclusions were reported and tools while simultaneously improving access to care for patients [33, 38] (Table 1) .

Nine studies were included in the meta-analysis. One study was excluded due to missing information on the variance of the net change in HbA1c values [32] . The pooled net change in HbA1c is presented in Fig. 2 . The Q test and I 2 statistics indicated insignificant heterogeneity (I 2 = 0.0%, p = 0.438). Although there was insignificant heterogeneity, the DerSimonian and Laird random-effects model was used to improve the generalizability of our findings. The z value of the test ES = 0 was − 4.972, p = 0.000. Therefore, the estimation of the pooled effect size is significant. We conclude that compared to the control group, telehealth intervention was significantly associated with a − 0.465% (CI: − 0.648 to − 0.282) reduction in HbA1c compared to other forms of routine care.

The results of the subgroup analysis are displayed in Fig. 3 . We found the pooled effect size was significant for patientlevel only telehealth interventions but not the two studies that used multi-target interventions.

To further assess the robustness of our findings, sensitivity analyses were conducted excluding studies with any white participants, that included only Hispanic participants, and those with multi-target interventions. The pooled effect size for studies that included Black and Hispanic diabetes patients exclusively was − 0. 

For reduction in HbA1c, the funnel plot demonstrates that the distribution of the net change estimates for individual studies was approximately symmetrical around the pooled net change estimate for trials comparing telehealth to a control group, suggesting a lack of publication bias. The trim and fill method verified this lack of publication bias (See Supplemental Appendix). In addition, the Egger test detected non-significant bias with a p value 0.514.

Our findings suggest telehealth interventions can be effective at improving glycemic control among Black and Hispanic diabetes patients. The findings are consistent with previous systematic reviews that found telehealth can improve glycemic control and other outcomes (e.g., medication adherence, goal achievement, and knowledge) through improved access to quality care (e.g., education, counseling, monitoring) [39] [40] [41] [42] . This review, however, is the first to analyze the subset of studies that have focused on Black and Hispanic diabetes patients. Most studies were published between 2015 and 2020. We found a relatively small number of experimental studies with a focus or substantial representation of Black and/or Hispanic patients. We found even fewer that implemented multi-target interventions, and no studies that focused on improving systems of health care delivery to better facilitate access to telehealth to improve diabetes care for Black and Hispanic patients.

In addition to computing the overall pooled effect size of telehealth interventions on glycemic control, we computed the effect sizes for various subgroups to compare the effects of telehealth on HbA1c according to patient race, study quality, and targeted intervention level. The effect of telehealth was significant in studies that included Black and Hispanic, as well as exclusively Hispanic populations. While the effect of telehealth interventions was significant in both groups, only two studies only included Hispanic populations, and thus the effect estimate is less precise. In addition to comparing the effects according to patient race, we analyzed the effects of study quality. While most studies belonged to the high risk of bias group, they contributed the least weight to the overall pooled effect estimate. Studies that were categorized as unclear and low risk of bias contributed the most weight to our overall pooled effect estimate due, in part, to more precise estimates of the effects. In addition, all quality subgroups indicated a significant effect of telehealth interventions on HbA1c reduction. When looking at the effect of intervention target, only patient-level interventions indicated a significant reduction in HbA1c. Only two studies targeted provider and patient-level factors, both had large confidence intervals, suggesting imprecise estimates of the effect. Finally, when assessing the robustness of our findings, we found that our results remained significant when removing studies that included White participants, only Hispanic participants, or multi-target interventions. Most studies used diabetes self-management education (DSME), that aims to improve knowledge and decisionmaking, as a primary intervention. DSME is an evidencebased strategy for improving glycemic control [43, 44] . The primary focus of DSME for glycemic control among Black and Hispanic patients implies that knowledge is a primary barrier to self-care. But it is unclear whether other barriers are more salient as studies rarely report an assessment of the barriers or specific behavioral issue their interventions aim to address. For example, Black and Hispanic patients are disproportionately less likely to have access to local healthy foods [45, 46] and may face barriers to consistently accessing insulin [47] . System-level telehealth interventions could involve information feedback loops that describe levels of food insecurity (i.e., food insecurity screened and if identified addressed), reimbursable digital tools for daily self-management, and low cost-sharing for treatment and prescription drugs. A spectrum of new digital connected services, machine learning, and advanced decision support tools will increasingly become available to support diabetes self-management [48] . These new technologies could be effective in addressing multiple barriers to glycemic control among Black and Hispanic patients.

Among the telehealth interventions that included multitarget strategies both targeted improving the effectiveness of community health workers-frontline health professionals who act as conduits between communities and health care providers. A recent meta-analysis of randomized control trials found community-health workers can be effective in helping patients improve glycemic control [50] . And studies have found telehealth interventions are feasible and acceptable for training community-health workers as well as enhancing their capacity to deliver glycemic control strategies like patient education and counseling [51] [52] [53] . Future work should assess the extent to which telehealth improves the effectiveness of community health workers in diabetes control interventions among racial and ethnic minorities.

The Covid-19 pandemic has led to significant changes in the financing and delivery of telehealth, which may improve access to care for diabetes patients from racial and ethnic minority groups. The Centers for Medicare and Medicaid Services (CMS)-through authority granted by the Coronavirus Aid, Relief, and Economic Security (CARES) Act-now recognizes patients' homes as an originating site, created payment parity with in-person services, and approved the telephone as a tool for conducting patient care [55] . However, these changes are temporary as they are only allowable for the duration of the pandemic. Section 1834(m) of the Social Security Act prohibits the CMS from paying for telehealth services delivered via two-way audio-visual technology unless care is provided at an eligible site in a rural area [49] . As lawmakers debate permanently expanding telehealth coverage, our findings provide evidence demonstrating the potential positive implications for Black and Hispanic patients with diabetes.

Our review had some limitations. Notably, interventions in our sample varied in the mode of telehealth, the intensity of contact with patients and health professionals, and the duration of the intervention making it difficult to comment on the specific strategy within these studies that led to improvements in glycemic control. Still, telehealth enables improved access to care (e.g., information, monitoring, counseling) regardless of the mode of delivery. The intensity or frequency of contact with patients across studies was dependent on the strategy, the need of individual patients, and the mode of telehealth. For instance, it is more feasible to have more frequent contact with patients using text-message-based interventions compared to synchronous virtual telehealth visits. Our review included studies that had a substantial representation of Black and Hispanic patients. Some studies had a higher proportion of White participants than others. And a significant portion of the studied we identified had a high risk of bias based on information reported or not reported to make an assessment (i.e., unclear). However, these studies contributed the least weight to our analyses. Our subgroup and sensitivity analyses indicated the magnitude and direction of the effect is the same or similar with these groups combined or separated. A significant strength of this study is our focus on Black and Hispanic patients with diabetes in the context of randomized control trials. Therefore, our findings reflect studies that were able to make causal claims about the impact of telehealth interventions on glycemic control among Black and Hispanic patients.

Telehealth interventions can be effective at improving glycemic control among Black and Hispanic diabetes patients. Most experiments that involve telehealth interventions among Black and Hispanic diabetes patients focused on exploring modes of delivering diabetes self-management education. These interventions are limited because they do not target the many other potential barriers to glycemic control among Black and Hispanic patients. Few studies have primarily aimed to improve glycemic control among Black and Hispanic patients using telehealth interventions. Our findings are relevant to policymakers as they decide whether and how to maintain and expand access to telehealth services. Future research should explore the use of telehealth, beyond knowledge for self-care, to address unique barriers to

Race/ethnic difference in diabetes and diabetic complications

Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence

Barriers to healthcare access in a non-elderly urban poor American population

Transportation as a barrier to cancer treatment

Traveling towards disease: transportation barriers to health care access

How structural racism works -racist policies as a root cause of U.S. racial health inequities

Structural racism and health inequities

Understanding and addressing racial disparities in health care

Digital disparities: designing telemedicine systems with a health equity aim

Strategies to reduce diabetes disparities: an update

Reaching the Latino population: a brief conceptual discussion on the use of telehealth to address healthcare disparities for the large and growing population

RESEARCHRacial and socioeconomic disparities in access to telehealth

Disparities in telehealth use among California patients with limited English proficiency

Tracking Healthy People 2020 Internet, broadband, and mobile device access goals: an update using data from the Health Information National Trends Survey

Disparities in use of telehealth at the onset of the COVID-19 public health emergency

Characteristics of telehealth users in NYC for COVID-related care during the coronavirus pandemic

Socioeconomic disparities in patient use of telehealth during the coronavirus disease 2019 surge

Home telehealth for chronic disease management: selected findings of a narrative synthesis

The impact of telehealth remote patient monitoring on glycemic control in type 2 diabetes: a systematic review and meta-analysis of systematic reviews of randomised controlled trials

Telemedicine in complex diabetes management

The inclusion of ethnic minority patients and the role of language in telehealth trials for type 2 diabetes: a systematic review

Interventions to reduce racial and ethnic disparities in health care

Connected health: a review of technologies and strategies to improve patient care with telemedicine and telehealth

Self-care in diabetes: model of factors affecting self-care

A systematic review of interventions to improve diabetes care in socially disadvantaged populations

Cochrane handbook for systematic reviews of interventions

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Methods for evidence synthesis in the case of very few studies

Telephone intervention to improve diabetes control: a randomized trial in the New York City A1c Registry

Effects of a tailored text messaging intervention among diverse adults with type 2 diabetes: evidence from the 15-month REACH randomized controlled trial

Effectiveness of technologically enhanced peer support in improving glycemic management among predominantly African American, lowincome adults with diabetes

Mobileenhanced peer support for African Americans with type 2 diabetes: a randomized controlled trial

Philis-Tsimikas A. Dulce digital: an mHealth SMS-based intervention improves glycemic control in Hispanics with type 2 diabetes. Diabetes Care

A patient-centric, provider-assisted diabetes telehealth self-management intervention for urban minorities

Telehealth improves diabetes selfmanagement in an underserved community

Telemedicine for disparity patients with diabetes: the feasibility of utilizing telehealth in the management of uncontrolled type 2 diabetes in Black and Hispanic disparity patients: a psilot study

A telehealth-supported, integrated care with CHWs, and MEdication-access (TIME) program for diabetes improves HbA1c: a randomized clinical trial

Impact of telehealth interventions on medication adherence for patients with type 2 diabetes, hypertension, and/or dyslipidemia: a systematic review

Interactive video telehealth models to improve access to diabetes specialty care and education in the rural setting: a systematic review

Home telehealth for diabetes management: a systematic review and meta-analysis

Telehealth for diabetes self-management in primary healthcare: a systematic review and meta-analysis

The effectiveness of diabetes self-management education (DSME) on glycemic control among T2DM patients randomized control trial: systematic review and metaanalysis protocol

Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control

Neighborhood disparities in access to healthy foods and their effects on environmental justice

Barriers to buying healthy foods for people with diabetes: evidence of environmental disparities

Overcoming barriers to glycemic control in African Americans with type-2 diabetes: benefits of insulin therapy

Telehealth in type 1 diabetes

Congress: act now to ensure telehealth access for medicare beneficiaries | Health Affairs Blog

Community health workers in diabetes care: a systematic review of randomized controlled trials

Evaluating the impact of telehealth-based, diabetes medication training for community health workers on glycemic control

Community health worker interventions to improve glycemic control in people with diabetes: a systematic review and meta-analysis

Telemedicine training and support for community health workers: improving knowledge of diabetes

Telehealth program for type 2 diabetes: usability, satisfaction, and clinical usefulness in an urban community health center

Important changes that may affect telehealth policy during the COVID-19 pandemic